Agreement announced on World Tuberculosis Day revitalizes efforts to develop sutezolid as effective response to infectious disease killer.

Médecins Sans Frontières (MSF) urges Sequella and Pfizer to provide open access to all existing clinical data for sutezolid to help accelerate the research and development of urgently needed new, lifesaving TB treatment regimes.

WHO and UNICEF issue joint statement on the use of child-friendly fixed-dose combinations for the treatment of TB in children.

The World Health Organization (WHO) recommends the use of a next-generation Xpert® MTB/RIF assay (called Xpert® MTB/RIF Ultra) as a replacement for the current Xpert MTB/RIF® cartridge.

Treatment Action Group, Health GAP, AIDS-Free World, and Treatment Action Campaign urge G20 leaders to fund research to end TB.

The Berlin TB Summit concluded with a call for G20 leaders to prioritize TB in their agenda ahead of the G20 Summit in July this year.

World TB Day 2017 – Unite efforts to leave no one behind

Companies and countries must take urgent action to increase access to these life-saving treatments.

The Stop TB Partnership is seeking applications for new TB Affected Communities Board Members. Application deadline: 31 March 2017.

Treatment Action Group (TAG) released a statement in strong opposition to the President’s 2018 budget blueprint.